Bank Of New York Mellon Corp V Tv Therapeutics Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$1.97 - $2.89 $1,243 - $1,823	-631 Reduced 2.69%	22,826 $64,000
Q4 2020 Feb 09, 2021	SELL	$1.49 - $3.1 $1,825 - $3,797	-1,225 Reduced 4.96%	23,457 $43,000
Q3 2020 Nov 12, 2020	BUY	$1.7 - $2.98 $1,014 - $1,779	597 Added 2.48%	24,682 $43,000
Q2 2020 Aug 12, 2020	BUY	$1.74 - $3.19 $41,907 - $76,831	24,085 New	24,085 $54,000
Q2 2018 Aug 06, 2018	SELL	$0.71 - $4.04 $15,600 - $88,770	-21,973 Closed	0 $0

Q4 2017 Feb 09, 2018	BUY	$3.9 - $7.77 $85,694 - $170,730	21,973	21,973 $132,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.